Booz Allen Hamilton Holding Corporation provides management and technology consulting, engineering, analytics, digital, mission operations, and cyber solutions to governments, corporations, and not-for-profit organizations in the United States and internationally. The company offers consulting solutions for various domains, business strategies, human capital, and operations. It also provides analytics services, which focuses on delivering transformational solutions in the areas of decision analytics, including operations research and cost estimation; automation; and data science, which include predictive modeling and machine learning, as well as new or emerging areas, such as deep learning and artificial intelligence. In addition, the company delivers engineering services and solutions to define, develop, implement, sustain, and modernize complex physical systems, such as the launch and test range system for the U.S. air force space command or the flush air data systems for NASA; and provides cyber risk management solutions, such as prevention, detection, and cost effectiveness. Further, it offers technical solutions in the areas of cybersecurity, command, control, communications, computers, intelligence, surveillance, and reconnaissance. Booz Allen Hamilton Holding Corporation was founded in 1914 and is headquartered in McLean, Virginia.
Industry, Sector and Symbol
Industry Management consulting services
Sub-IndustryIT Consulting & Other Services
SectorBusiness Services
Phone703-902-5000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$6.17 billion
Profitability
Miscellaneous
Employees24,600
Next Earnings Date5/28/2019 (Confirmed)
OptionableOptionable
Booz Allen Hamilton (NYSE:BAH) Frequently Asked Questions
What is Booz Allen Hamilton's stock symbol?
Booz Allen Hamilton trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAH."
How often does Booz Allen Hamilton pay dividends? What is the dividend yield for Booz Allen Hamilton?
Booz Allen Hamilton declared a quarterly dividend on Monday, February 4th. Stockholders of record on Thursday, February 14th will be paid a dividend of $0.23 per share on Thursday, February 28th. This represents a $0.92 annualized dividend and a dividend yield of 1.57%. The ex-dividend date of this dividend is Wednesday, February 13th. This is a boost from Booz Allen Hamilton's previous quarterly dividend of $0.19. View Booz Allen Hamilton's Dividend History.
How were Booz Allen Hamilton's earnings last quarter?
Booz Allen Hamilton Holding Co. (NYSE:BAH) issued its earnings results on Friday, February, 1st. The business services provider reported $0.72 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.58 by $0.14. The business services provider had revenue of $1.66 billion for the quarter, compared to analysts' expectations of $1.60 billion. Booz Allen Hamilton had a return on equity of 61.40% and a net margin of 6.31%. The company's quarterly revenue was up 13.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.51 earnings per share. View Booz Allen Hamilton's Earnings History.
When is Booz Allen Hamilton's next earnings date?
What guidance has Booz Allen Hamilton issued on next quarter's earnings?
Booz Allen Hamilton issued an update on its FY19 earnings guidance on Friday, February, 1st. The company provided earnings per share guidance of $2.65-2.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.64. The company issued revenue guidance of $6.60-6.67 billion (+7-8% previously saw +6-8%), compared to the consensus revenue estimate of $6.63 billion.Booz Allen Hamilton also updated its FY 2019 guidance to $2.65-2.75 EPS.
What price target have analysts set for BAH?
9 analysts have issued 12-month target prices for Booz Allen Hamilton's stock. Their forecasts range from $50.00 to $58.00. On average, they expect Booz Allen Hamilton's stock price to reach $53.7143 in the next year. This suggests that the stock has a possible downside of 8.4%. View Analyst Price Targets for Booz Allen Hamilton.
What is the consensus analysts' recommendation for Booz Allen Hamilton?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Booz Allen Hamilton in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Booz Allen Hamilton.
What are Wall Street analysts saying about Booz Allen Hamilton stock?
Here are some recent quotes from research analysts about Booz Allen Hamilton stock:
- 1. According to Zacks Investment Research, "Booz Allen Hamilton is currently in the process of implementing Vision 2020, the strategy aimed at achieving sustainable long-term growth, is progressing well as it is seeing significantly higher backlog growth, shift in talent to more technical expertise and a strong performance in the global commercial market. The company is also focussing on innovation areas such as Machine Intelligence and Directed Energy, thereby ensuring business development over the long haul. The stock has outperformed its industry in a year's time. On the flip side, Booz Allen could see an escalation in capital expenditure due to higher investments in facilities, systems, infrastructure and technology. Seasonality continues to weigh on the company’s profitability. High debt may weigh on the company's future expansion and worsen its risk profile." (4/9/2019)
- 2. Drexel Hamilton analysts commented, "We are adjusting our FY 2019 estimates to reflect 1Q’19. For FY 2019 we are raising our revenue estimate from $6.5B to $6.6B, our EBITDA from $621M to $635M, and our to $2.46. We are establishing FY 2020 estimates of $7.0B in revenue, $699M in Adjusted EPS." (7/30/2018)
- 3. SunTrust Banks, Inc. analysts commented, "We have previously commented in a note our continued interest in TPIV’s strategic move to merge with Marker, as the clinical assets carry data that cannot be overlooked, and the proposed management, advisory, as well as directorship of the combined company place prominence on TPIV to be a leader in the cell therapy space. We are reiterating that thesis in this report and again look with greater enthusiasm towards the closing of this transaction and the development of a new company. We therefore raising our and maintaining our price target of $5.50." (5/30/2018)
Has Booz Allen Hamilton been receiving favorable news coverage?
Headlines about BAH stock have been trending somewhat positive this week, InfoTrie reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Booz Allen Hamilton earned a media sentiment score of 1.6 on InfoTrie's scale. They also assigned news coverage about the business services provider a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future.
Are investors shorting Booz Allen Hamilton?
Booz Allen Hamilton saw a increase in short interest during the month of March. As of March 15th, there was short interest totalling 3,279,914 shares, an increase of 49.9% from the February 28th total of 2,187,703 shares. Based on an average daily trading volume, of 1,328,772 shares, the short-interest ratio is currently 2.5 days. Currently, 2.4% of the shares of the company are sold short. View Booz Allen Hamilton's Current Options Chain.
Who are some of Booz Allen Hamilton's key competitors?
Some companies that are related to Booz Allen Hamilton include Capgemini (CGEMY), CGI (GIB), Genpact (G), FTI Consulting (FCN), Exponent (EXPO), RMR Group (RMR), ICF International (ICFI), NIC (EGOV), Huron Consulting Group (HURN), Navigant Consulting (NCI), Apollo Medical (AMEH), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO) and Information Services Group (III).
What other stocks do shareholders of Booz Allen Hamilton own?
Who are Booz Allen Hamilton's key executives?
Booz Allen Hamilton's management team includes the folowing people:
- Mr. Horacio D. Rozanski, CEO, Pres & Director (Age 51)
- Mr. Lloyd W. Howell Jr., Exec. VP, CFO & Treasurer (Age 52)
- Ms. Karen M. Dahut, Exec. VP & Global Defense Group Lead (Age 55)
- Ms. Susan L. Penfield, Chief Innovation Officer & Exec. VP (Age 57)
- Ms. Laura S. Adams, Chief Accounting Officer, VP & Controller (Age 46)
Who are Booz Allen Hamilton's major shareholders?
Booz Allen Hamilton's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Hennessy Advisors Inc. (0.24%), Polaris Greystone Financial Group LLC (0.11%), Boston Advisors LLC (0.07%), Brinker Capital Inc. (0.04%), Landsberg Bennett & Dubbaneh LLC (0.03%) and KAMES CAPITAL plc (0.02%). Company insiders that own Booz Allen Hamilton stock include Charles O Rossotti, Christopher Ling, Elizabeth M Thompson, Gary D Labovich, Gretchen W Mcclain, Horacio Rozanski, Ian Fujiyama, Joseph Logue, Joseph W Mahaffee, Karen M Dahut, Kristine Anderson, Lloyd Howell, Jr, Melody C Barnes, Nancy Laben, Peter J Clare, Ralph W Shrader and Susan L Penfield. View Institutional Ownership Trends for Booz Allen Hamilton.
Which institutional investors are selling Booz Allen Hamilton stock?
BAH stock was sold by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., Highland Capital Management LLC, State of Alaska Department of Revenue, First Command Bank, Strs Ohio and Oakbrook Investments LLC. Company insiders that have sold Booz Allen Hamilton company stock in the last year include Charles O Rossotti, Christopher Ling, Elizabeth M Thompson, Gary D Labovich, Gretchen W Mcclain, Horacio Rozanski, Joseph Logue, Kristine Anderson, Nancy Laben, Ralph W Shrader and Susan L Penfield. View Insider Buying and Selling for Booz Allen Hamilton.
Which institutional investors are buying Booz Allen Hamilton stock?
BAH stock was bought by a variety of institutional investors in the last quarter, including Polaris Greystone Financial Group LLC, KAMES CAPITAL plc, Brinker Capital Inc., Pennsylvania Trust Co, Pennsylvania Trust Co, W.E. Donoghue & Co. LLC, Brookstone Capital Management and Meeder Asset Management Inc.. Company insiders that have bought Booz Allen Hamilton stock in the last two years include Ian Fujiyama and Peter J Clare. View Insider Buying and Selling for Booz Allen Hamilton.
How do I buy shares of Booz Allen Hamilton?
Shares of BAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Booz Allen Hamilton's stock price today?
One share of BAH stock can currently be purchased for approximately $58.65.
How big of a company is Booz Allen Hamilton?
Booz Allen Hamilton has a market capitalization of $8.22 billion and generates $6.17 billion in revenue each year. The business services provider earns $305.11 million in net income (profit) each year or $2.01 on an earnings per share basis. Booz Allen Hamilton employs 24,600 workers across the globe.
What is Booz Allen Hamilton's official website?
How can I contact Booz Allen Hamilton?
Booz Allen Hamilton's mailing address is 8283 Greensboro Drive, McLean VA, 22102. The business services provider can be reached via phone at 703-902-5000 or via email at [email protected]
MarketBeat Community Rating for Booz Allen Hamilton (NYSE BAH)
MarketBeat's community ratings are surveys of what our community members think about Booz Allen Hamilton and other stocks. Vote "Outperform" if you believe BAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAH will underperform the S&P 500 over the long term. You may vote once every thirty days.
